(Q34165809)

31 July 2017

title

RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy (English)

1 reference

31 July 2017

0 references

1 reference

Shunrong Ji

1

1 reference

31 July 2017

Jin Xu

2

1 reference

31 July 2017

Bo Zhang

3

1 reference

31 July 2017

Wantong Yao

4

1 reference

31 July 2017

Wenyan Xu

5

1 reference

31 July 2017

Wenzhe Wu

6

1 reference

31 July 2017

Yongfeng Xu

7

1 reference

31 July 2017

Hao Wang

8

1 reference

31 July 2017

Quanxing Ni

9

1 reference

31 July 2017

Huimin Hou

10

1 reference

31 July 2017

Xianjun Yu

11

1 reference

31 July 2017

publication date

1 February 2012

1 reference

Cancer Biology and Therapy

31 July 2017

published in

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

206-215

1 reference

31 July 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Pancreatic cancer in sweden 1980-2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Determinants of resistance to 2',2'-difluorodeoxycytidine (gemcitabine).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Novel approaches to deliver gemcitabine to cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Spectroscopic studies on the interaction of bovine (BSA) and human (HSA) serum albumins with ionic surfactants.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

RGD peptides induce apoptosis by direct caspase-3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

RGD peptide-induced apoptosis in human leukemia HL-60 cells requires caspase-3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Human melanoma cells expressing the alphavbeta3 integrin are partially protected from necrotic cell death induced by dynamic matrix detachment.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Uptake of oleoyl-chitosan nanoparticles by A549 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Integrin alphaVbeta3 targeted gene delivery using RGD peptidomimetic conjugates with copolymers of PEGylated poly(ethylene imine).

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Radiotherapy combined with gemcitabine and oxaliplatin in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FCBT.13.4.18692

21 January 2018

Identifiers

DOI

10.4161/CBT.13.4.18692

1 reference

31 July 2017

1 reference